PFIZER INC Stock Repurchase Program, Authorized Amount
PFIZER INC (PFE) had Stock Repurchase Program, Authorized Amount of $6.80 billion as of 2019-02-07, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2020-02-27
- 2019-02-07: Stock Repurchase Program, Authorized Amount $6.80B.
- 2018-03-12: Stock Repurchase Program, Authorized Amount $4.00B.
- 2016-03-08: Stock Repurchase Program, Authorized Amount $5.00B.
- 2015-12-31: Stock Repurchase Program, Authorized Amount $11.00B.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2019-02-07 | $6.80B 10-Q · filed 2019-11-07 |
| 2018-03-12 | $4.00B 10-Q · filed 2018-11-08 |
| 2016-03-08 | $5.00B 10-K · filed 2019-02-28 |
| 2015-12-31 | $11.00B 10-K · filed 2017-02-23 |
| 2014-10-23 | $11.00B 10-K · filed 2020-02-27 |
| 2013-06-27 | $10.00B 10-K · filed 2018-02-22 |
| 2012-11-30 | $10.00B 10-K · filed 2016-02-29 |
| 2012-11-01 | $10.00B 10-K · filed 2015-02-27 |
| 2011-12-31 | $10.00B 10-K · filed 2016-02-29 |
| 2011-12-12 | $10.00B 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |